Symbyax, a drug for treatment-resistant bipolar 1 depression got FDA clearance today. Symbyax is the first-ever drug to get official clearance for treatment-resistant bipolar 1 depression. Symbyax, made by ELi Lilly, is a combination of olanzapine and fluoxetine HCl capsules.